Skip to main content
Premium Trial:

Request an Annual Quote

Samraat Raha, Brad Walsh, Grant Cameron


EraGen Biosciences has appointed Samraat Raha Chief Business Officer, the Madison, Wis.-based company said last week. Raha will be responsible for EraGen’s overall business development, sales, and marketing efforts. In his most recent position, Raha served as vice president of discovery services at Incyte Genomics, where he oversaw the company’s genomic service businesses, including microarrays and bioreagents. Raha has a BA in molecular and cell biology from the University of California, Berkeley.

After leaving the Australian Proteomics Analysis Facility earlier this year, Brad Walsh has started his own company, ProteoMeca. Walsh will serve as CEO of the new proteomics discovery company, which is planning to apply proteomics to agriculture and bacterial systems. ProteoMeca is based in Harbord, Australia.

Grant Cameron has joined Cambridge, UK-based NextGen Sciences as European Commercial Director. Cameron previously served as business director for Sense Proteomic.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.